Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 9, Issue 2, pp. 400-409
PubMed
Published By
Print ISSN
Online ISSN
History
- Received September 2, 2009
- Revision received November 6, 2009
- Accepted December 6, 2009
- Published first February 2, 2010.
Article Versions
- Previous version (February 2, 2010 - 08:57).
- You are viewing the most recent version of this article.
Copyright & Usage
©2010 American Association for Cancer Research.
Author Information
- Teresa L. Burgess1,
- Jan Sun1,
- Susanne Meyer5,
- Trace S. Tsuruda2,
- Jilin Sun3,
- Gary Elliott4,
- Qing Chen2,
- Mitsuru Haniu2,
- Will F. Barron2,
- Todd Juan2,
- Ke Zhang6,
- Angela Coxon1 and
- Richard L. Kendall1
- Authors' Affiliations: 1Oncology Research, 2Protein Science, 3Clinical Immunology, and 4High Throughput Screening-Molecular Pharmacology, Amgen Inc., Thousand Oaks, California; 5Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, California; and 6Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland
- Corresponding Author:
Teresa L. Burgess, Amgen Inc., One Amgen Center Drive, M/S 14-1-B, Thousand Oaks, CA 91320-1799. Phone: 805-447-2493; Fax: 1-805-375-8368. E-mail: tburgess{at}amgen.com
February 2010
Volume 9, Issue 2
Volume 9, Issue 2
Biochemical Characterization of AMG 102: A Neutralizing, Fully Human Monoclonal Antibody to Human and Nonhuman Primate Hepatocyte Growth Factor
Jump to section
Advertisement